Revance Therapeutics shares owned by Balyasny Asset Management
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Balyasny Asset Management
from 13F filings
Historical chart of Balyasny Asset Management investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Balyasny Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.2M | 363k | 8.79 |
| 2023-09-30 | $5.4M | 470k | 11.47 |
| 2018-09-30 | $205k | 8.3k | 24.81 |
| 2018-06-30 | $312k | 11k | 27.45 |
| 2015-12-31 | $261k | 7.6k | 34.21 |
| 2015-09-30 | $3.3M | 112k | 29.76 |
| 2015-03-31 | $1.7M | 80k | 20.73 |